Aura Biosciences annual operating expenses
2020
2021
2022
2023
2024
2025
Aura Biosciences Operating Expenses Growth & History (AURA)
Aura Biosciences's operating expenses was $112.8M for fiscal 2025.
View full Aura Biosciences company overviewAura Biosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $112.8M | $16.7M | +17.35% |
| 2024 | 2024-12-31 | $96.1M | $11.1M | +13.09% |
| 2023 | 2023-12-31 | $85.0M | $24.7M | +40.96% |
| 2022 | 2022-12-31 | $60.3M | $25.0M | +71.05% |
| 2021 | 2021-12-31 | $35.3M | $13.0M | +58.74% |
| 2020 | 2020-12-31 | $22.2M | — | — |
Aura Biosciences quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $48.1M | $19.5M | +68.00% |
| Q1 2026 | 2026-03-31 | $34.9M | $5.8M | +20.08% |
| Q4 2025 | 2025-12-31 | $27.2M | −$572,000 | −2.06% |
| Q3 2025 | 2025-09-30 | $27.9M | $4.7M | +20.12% |
| Q2 2025 | 2025-06-30 | $28.6M | $5.9M | +25.71% |
| Q1 2025 | 2025-03-31 | $29.0M | $6.7M | +30.13% |
| Q4 2024 | 2024-12-31 | $27.8M | $3.0M | +12.21% |
| Q3 2024 | 2024-09-30 | $23.2M | $2.7M | +13.39% |
| Q2 2024 | 2024-06-30 | $22.8M | $2.5M | +12.26% |
| Q1 2024 | 2024-03-31 | $22.3M | $2.9M | +14.76% |
| Q4 2023 | 2023-12-31 | $24.8M | $7.2M | +40.71% |
| Q3 2023 | 2023-09-30 | $20.5M | $4.4M | +27.61% |
| Q2 2023 | 2023-06-30 | $20.3M | $6.5M | +46.76% |
| Q1 2023 | 2023-03-31 | $19.4M | $6.6M | +51.78% |
| Q4 2022 | 2022-12-31 | $17.6M | $6.0M | +51.48% |
| Q3 2022 | 2022-09-30 | $16.1M | $7.2M | +80.49% |
| Q2 2022 | 2022-06-30 | $13.8M | $5.0M | +56.98% |
| Q1 2022 | 2022-03-31 | $12.8M | $6.9M | +116.15% |
| Q4 2021 | 2021-12-31 | $11.6M | — | — |
| Q3 2021 | 2021-09-30 | $8.9M | $5.3M | +144.97% |
| Q2 2021 | 2021-06-30 | $8.8M | — | — |
| Q1 2021 | 2021-03-31 | $5.9M | — | — |
| Q3 2020 | 2020-09-30 | $3.6M | — | — |
Aura Biosciences operating expenses trends
Over the last five fiscal years, Aura Biosciences's operating expenses increased from $22.2M to $112.8M, a change of $90.6M. The latest reported quarter, Q2 2026, shows $48.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aura Biosciences source filings ↗